SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

TTK Healthcare’s Q2 net profit dips 10%

24 Oct 2013 Evaluate

TTK Healthcare has reported results for the second quarter ended September 30, 2013.

The company has reported 10.40% fall in its net profit at Rs 3.62 crore for the quarter as compared to Rs 4.04 crore for the same quarter in the previous year. However, total income from operations of the company has increased by 5.32% at Rs 100.72 crore for quarter under review as compared to Rs 95.63 crore for the quarter ended September 30, 2012.

TTK Healthcare brand wagon consists of products that are sought after by a wide range of customers. It has an all India sales and distribution network for marketing not only their own products, but also the KIWI Brand (Shoecare), Brylcreem (Haircare) and Kohinoor and Durex brands (Contraceptives).

TTK Healthcare Share Price

887.80 13.45 (1.54%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Grasim Industries 2757.45
DCM Shriram 1198.95
3M India 31427.05
Hindustan Foods 494.80
Balmer Lawrie & Co 177.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×